Effects of Janus Kinase Inhibitor tofacitinib on circulating serum amyloid A and interlukin-6 during treatment for rheumatoid arthritis
Clinical and Experimental Immunology doi.10.1111/cei.12234
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Clinical and Experimental Immunology doi.10.1111/cei.12234
. ARD published online first 13 Feb 2014. Doi: 10.1136/annrheumdis-2013-204105
Arthritis and Rheumatology March 2014:66;513-522
The Lancet, Volume 383, Page S22, 26 February 2014
Tissue Engineering Part A doi:10/1089/ten.TEA.2013.0553
Rheumatology doi:10.1093/rheumatology/ket414
Rheumatology doi:10.1093/rheumatology/ket466
Chemistry and Biology Nov 13 20, 1364-1374
Arthritis and Rheumatism doi: 10.1002/art.38305
Ann Rheum Dis 2013. doi: 10.1136/annrheumdis-2013-203756